This article reviews recent research on the short- and long-term effects of developmental ethanol[^1^](#fn2-arh-34-1-106){ref-type="fn"} (i.e., alcohol) exposure on brain chemical (i.e., neurotransmitter) systems. The article focuses on studies that were performed with tissue from animal models, including rats, mice, guinea pigs, and primates. It is noteworthy that prenatal development in rats and mice corresponds to the first and second trimesters of human pregnancy, whereas the first week of neonatal life corresponds to the third trimester. In guinea pigs and primates, intrauterine development more closely corresponds to the first, second, and third trimesters of human pregnancy. It also is important to keep in mind that the studies in this research area are quite heterogeneous in several respects, including the timing, duration, and route of ethanol exposure; the levels of ethanol that were achieved in blood; and the techniques used to assess the effects of ethanol exposure. Regarding blood ethanol levels, it should be emphasized that the legal intoxication limit for driving is 0.08 g/dl and that, in some cases, developmental exposures to much higher ethanol levels were required to produce significant effects (see [table 1](#t1-arh-34-1-106){ref-type="table"}). Ethanol concentrations near 0.4 g/dl are typically lethal in individuals who do not regularly drink significant amounts of ethanol and have not developed tolerance to its depressant effects on brain activity. Therefore, care must be exercised when interpreting the results of studies that have used high concentrations of ethanol. This article first provides background information on neurotransmitter systems and their roles in normal central nervous system development and neurodevelopmental disorders. It then reviews studies on the actions of ethanol on two types of neurotransmitter systems: amino acids and biogenic amines. For the most part, the article reviews research published in the past decade. The reader is referred to more comprehensive review articles for additional information ([@b11-arh-34-1-106]; [@b17-arh-34-1-106]; [@b25-arh-34-1-106]; [@b75-arh-34-1-106]; [@b79-arh-34-1-106]). [Figure 1](#f1-arh-34-1-106){ref-type="fig"} illustrates some of the mechanisms by which developmental ethanol exposure could impair chemical neurotransmitter systems.

Neurotransmitter Systems and Normal Central Nervous System Development
======================================================================

Efficient communication among large numbers of brain cells (i.e., neurons) is necessary for the normal functioning of the nervous system. A central mechanism of neuronal communication involves the release of neurotransmitters that bind to specialized receptors on the target cell, changing its activity. Although neuropeptides are an important category of neurotransmitters involved in neuronal communication and the developmental actions of ethanol, they are beyond the scope of this article. This article will focus on chemical neurotransmitters, which can be divided into three classes: (1) amino acids (e.g., γ-aminobutyric acid \[GABA\], glycine, and glutamate); (2) biogenic amines (e.g., serotonin, dopamine, norepinephrine, epinephrine, and histamine); and (3) other (e.g., acetylcholine, adenosine triphosphate, and adenosine). This review focuses on the actions of ethanol on the GABA, glutamate, serotonin, and dopamine neurotransmitter systems in the developing brain. Neurons synthesize these neurotransmitters and package them in vesicles that typically are localized at the ends of projections known as axons. Neuronal activation causes the release of neurotransmitters from the axonal terminals onto branch-like projections in adjacent neurons, which are called dendrites. Dendrites contain small thorn-like protrusions known as dendritic spines. Axonal terminals and dendritic spines meet at specialized points of contact, called synapses, which mediate a significant portion of information exchange between neurons (see [figure 1](#f1-arh-34-1-106){ref-type="fig"}). Neurotransmitter receptors are not only expressed in target cell dendrites but also in axonal terminals, where these receptors regulate neurotransmitter release (see [figure 1](#f1-arh-34-1-106){ref-type="fig"}). Reuptake into the axonal terminal or neighboring support cells (i.e., glial cells) or enzymatic breakdown decreases synaptic levels of the chemical neurotransmitter, terminating its action.

Neurotransmission in the mature central nervous system relies on the proper assembly of synapses during development, a process that requires multiple steps. Development of the nervous system begins with the recruitment of progenitor cells (precursors of neurons and glial cells) into a specialized structure called the neural plate. The neural plate then folds to form the neural tube, which subdivides in a complex manner. The anterior and posterior regions of the neural tube ultimately give rise to the brain and spinal cord, respectively. Within the neural tube, progenitor cells are transformed into neuronal and glial cells. Immature neurons migrate to their final locations and gradually acquire axons, dendrites, and synapses. Information exchange between axons and dendrites determines whether synapses are maintained or eliminated, and chemical neurotransmitters play important roles in each of these neuronal developmental steps. Even before synapses are formed, GABA and glutamate regulate progenitor cell proliferation, migration, and differentiation ([@b44-arh-34-1-106]). These neurotransmitters could be released from growing axons via reverse action of neurotransmitter transporters that normally pump neurotransmitters into the axonal terminal. In immature neurons, glutamate and GABA contribute to the maturation of dendrites and axons and also are directly involved in the generation and refinement of synaptic contacts ([@b16-arh-34-1-106]). Neurotransmitter systems have different properties during development and maturity. For instance, neurons throughout the developing central nervous system generate oscillatory electrical activity that plays a central role in the construction of neuronal networks. These unique properties contribute to the formation and maturation of neuronal circuits and also make immature neuronal networks particularly susceptible to genetic or environmental insults ([@b10-arh-34-1-106]).

Role of Alterations in Neurotransmitter Systems in Neurodevelopmental Disorders
===============================================================================

Multiple studies have identified neurotransmitter systems as major substrates of neurodevelopmental disorders, including autism, Down syndrome, and fetal alcohol spectrum disorders (FASD). Although these conditions have different causes, they are all characterized by altered neuronal communication that can be explained by underlying deficiencies in synapse development. Ethanol exposure during development has been shown to cause long-lasting defects in both the structure and function of synapses. Several mechanisms could underlie these persistent defects. Death, abnormal migration, or arrested maturation in a population of neurons will deprive their targets from receiving appropriate synaptic inputs, allowing for abnormal synaptic connections to be formed.

Even if synapses are formed properly, ethanol can affect the normal progression of their developmental program, which involves stabilization of functional synapses and pruning of unneeded synapses. Importantly, these synaptic refinement processes are regulated by chemical neurotransmission and require equilibrium (also known as homeostasis) between inhibitory and excitatory influences ([@b62-arh-34-1-106]). This equilibrium can be altered by genetic defects, such as in the case of Fragile X syndrome, which is characterized by deficits in excitatory synaptic transmission mediated by the amino acid transmitter glutamate; or exposure to toxic agents such as ethanol, which, as discussed below, produces complex effects on the balance between excitatory and inhibitory neurotransmitters. In response to these perturbations, developing neurons attempt to restore equilibrium with compensatory changes that often involve increases or decreases in the function of proteins (e.g., neurotransmitter receptors) involved in chemical neurotransmission. These compensatory changes are not always able to restore equilibrium, and this slows down or accelerates developmental programs, causing abnormal assembly of neuronal circuits and long-lasting alterations in chemical neurotransmission. The precise chain of events leading from developmental insult-induced alterations in neurotransmitter systems to persistent neurochemical alterations during adulthood is currently unknown. In the case of developmental ethanol exposure, this issue is very difficult to study because drinking during pregnancy can occur in many different patterns---for instance, single versus repeated exposure, ingestion of low versus high amounts of ethanol, and exposure during early versus late pregnancy. The studies reviewed below are quite heterogeneous, involving diverse animal models, patterns of developmental ethanol exposure, and study end points. Significant progress has been made in this area of research in recent years, as reviewed below.

GABA
====

GABA is synthesized from glutamate by the enzyme glutamate decarboxylase and is the main inhibitory transmitter in the mature mammalian brain. Two classes of receptors---the GABA~A~ and GABA~B~ receptors---mediate the actions of this neurotransmitter. Most studies related to FASD have focused on GABA~A~ receptors, which are GABA-activated ion channels that are permeable to chloride ions (Cl^−^). When these receptors are activated by GABA in mature neurons, Cl^−^ flows into the cell making the membrane potential more negative and thereby decreasing excitability of the neuron (see [figure 2](#f2-arh-34-1-106){ref-type="fig"}). However, when these receptors are activated in immature neurons, Cl^−^ flows out of the cell, making the membrane potential more positive. Therefore, in contrast to its effects on mature neurons, GABA can actually excite immature neurons (see [figure 2](#f2-arh-34-1-106){ref-type="fig"}) ([@b9-arh-34-1-106]). These excitatory actions of GABA during development contribute to its involvement in the control of neuronal growth, neuronal migration, and synapse formation/refinement. In rodents, the function of GABA~A~ receptors switches from excitatory to inhibitory at the end of the period equivalent to the third trimester (i.e., by postnatal days 10 to 12).

Developmental Ethanol Exposure and GABA
---------------------------------------

Two recent studies highlight the importance of ethanol's actions on the GABA neurotransmitter system during early developmental stages. The first study concerns the effect of ethanol on the generation of new neurons in the cerebral cortex. [@b67-arh-34-1-106] showed that fetal mouse cerebral cortical progenitor cells exposed to ethanol for 5 days (0.32 g/dl) decreased expression of small noncoding messenger RNA regulatory molecules (microRNAs), and the coordinated effects of ethanol on these microRNAs triggered premature maturation of the progenitor cells. The mechanism of action of ethanol involved, in part, activation of GABA~A~ receptors in the progenitor cells. The second study addressed the effect of ethanol on neuronal migration, demonstrating that exposing mice to a low concentration of ethanol in utero (see [table 1](#t1-arh-34-1-106){ref-type="table"}) promoted premature migration of immature GABA interneurons into the cerebral cortex ([@b18-arh-34-1-106]). Studies with cortical slices suggested that ethanol produces premature migration of immature GABAergic interneurons by increasing both ambient GABA levels and GABA~A~ receptor activation, which could act by stimulating these interneurons (see [figure 2](#f2-arh-34-1-106){ref-type="fig"}). These findings suggest that daily consumption of small amounts of ethanol (such as a glass of wine with meals) during the first and second trimesters of pregnancy could have significant effects on the development of GABAergic neurons in the fetus. Given the prominent role of GABA during development, this could significantly affect the normal development of cortical neuronal circuits. Collectively, these studies emphasize that ethanol can affect the function of the GABA neurotransmitter system even before synapses have been formed and that neurochemical imbalances can have profound consequences on early neuronal development.

During later stages of development, ethanol exposure also affects the maturation of GABAergic transmission. [@b30-arh-34-1-106] showed that administration of ethanol to rat pups via oral intubation during the third trimester--equivalent period ([table 1](#t1-arh-34-1-106){ref-type="table"}) delays the developmental increase of GABA~A~ receptor--mediated currents in medial septum/diagonal band neurons, which are involved in modulation of attention, memory, and other cognitive functions. Because these processes are altered in FASD patients, future studies should investigate whether this is a consequence of deficits in the maturation of GABA input to these neurons.

Potent effects of ethanol exposure on GABA transmission during the third trimester--equivalent period also have been documented in the hippocampus---another brain region that is important for learning and memory processes. In a specific population of hippocampal neurons---namely, those located in the CA3 region---a primitive pattern of neuronal network oscillations has been well characterized. These oscillations are driven, in part, by the above-mentioned excitatory actions of GABA~A~ receptors (see [figure 2](#f2-arh-34-1-106){ref-type="fig"}). [@b24-arh-34-1-106] demonstrated that acute ethanol exposure increases GABA release in the CA3 hippocampal region in brain slices from neonatal rats. This effect was produced by ethanol concentrations as low as 0.05 g/dl and ultimately results in an increase in neuronal oscillations. Whether ethanol also affects the switch in the actions of the GABA~A~ receptors from excitatory to inhibitory currently is under investigation.

Given that oscillatory network activity is thought to be important for the maturation of neuronal circuits in the hippocampus and other brain regions of several animal species including humans ([@b52-arh-34-1-106]), it is possible that this effect of ethanol impairs the formation and/or refinement of synapses even when ethanol is consumed at low levels during late pregnancy. The oscillations control neuronal development by triggering changes in the activity of genes and/or inducing the release of trophic factors (from the Greek *trophe*, to nourish) that stabilize neuronal connections ([@b51-arh-34-1-106]).

A recent study by [@b86-arh-34-1-106] characterized the effect of ethanol on the release of trophic factors in the CA3 hippocampal region. Stimulation of pyramidal-shaped neurons in this region causes the dendritic release of a protein known as brain-derived neurotrophic factor (BDNF), which induces a long-lasting enhancement (i.e., potentiation) of GABA transmission that is thought to be essential for the maturation of GABA inputs to these neurons ([@b22-arh-34-1-106]). The researchers found that acute exposure to ethanol inhibits this BDNF-mediated potentiation of GABA transmission in hippocampal slices. This effect was very potent, reaching significance at concentrations as low as 0.025 g/dl, and was mediated by inhibition of the [l]{.smallcaps}-type category of voltage-gated calcium ion (Ca^2+^) channels that trigger the dendritic release of BDNF. This effect also was observed after repeated in vivo exposures to low doses of ethanol. Inhibition of this BDNF-dependent form of synaptic potentiation is likely to have a deleterious effect on the maturation of inhibitory circuits in the CA3 hippocampal region, causing an imbalance between excitatory and inhibitory synaptic transmission, and ultimately resulting in alterations in learning, memory, and other cognitive processes.

Developmental ethanol-induced alterations of GABA functioning also can produce long-lasting changes in neuronal circuits by inducing neuronal death. Exposure to high levels of ethanol (≥g/dl) during the third trimester--equivalent period was shown to cause widespread neuronal death in rats ([@b33-arh-34-1-106]). This effect partially was mimicked by the administration of drugs such as barbiturates that enhance GABA~A~ receptor function and the researchers hypothesized that ethanol triggered cell death by inducing excessive inhibition of neuronal activity via GABA~A~ receptor potentiation. However, [@b66-arh-34-1-106] failed to demonstrate that ethanol directly enhances GABA~A~ receptor--mediated inhibition of cortical neurons in slices from neonatal rats, which is surprising given that these neurons were shown to be particularly sensitive to ethanol-induced cell death ([@b33-arh-34-1-106]).

Persistent alterations in the GABA system could be responsible for behavioral abnormalities observed in the adult offspring from animals exposed to single or multiple doses of ethanol during development. However, the mechanisms responsible for these effects are presently unknown, including the possible connection between these persistent changes and any of the above-described effects of ethanol on the developing GABA neurotransmitter system. In one study of guinea pigs repeatedly exposed to high ethanol concentrations throughout pregnancy, researchers found persistent alterations in GABA transmission (see [table 1](#t1-arh-34-1-106){ref-type="table"}) and increased levels of certain GABA~A~ receptor subunits (α~1~ and/or β~2/3~) in the cerebral cortex and hippocampus of adult offspring ([@b3-arh-34-1-106]). This effect could have occurred in response to reduced numbers of GABA neurons or a decrease in the enzymes essential to GABA synthesis ([@b3-arh-34-1-106], [@b4-arh-34-1-106]). Similarly, elevated levels of the α~5~ GABA~A~ receptor subunit were found in the brains of adult mice exposed to a single ethanol dose during gestational day 8 (neonatal ethanol levels expected to be near 0.5 g/dl) ([@b73-arh-34-1-106]; [@b78-arh-34-1-106]). GABA~A~ receptors containing the α~5~ subunit are expressed outside the synaptic area (see [figure 1](#f1-arh-34-1-106){ref-type="fig"}) and exert a persistent inhibitory control on neurons in the hippocampus and other brain regions, including the cerebral cortex ([@b57-arh-34-1-106]).

A study of adolescent monkeys exposed to ethanol in utero found reduced numbers of GABA neurons in the cerebral cortex (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b50-arh-34-1-106]). Persistent dysfunction and/or loss of GABA neurons could, in part, be responsible for the increased susceptibility to epilepsy that has been linked to FASD ([@b8-arh-34-1-106]; [@b12-arh-34-1-106]). In addition, alterations in the function of a subtype of GABA neuron (i.e., the Purkinje neuron) in the cerebellum, a brain region important for motor coordination (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}), could contribute to motor deficits observed in FASD patients ([@b26-arh-34-1-106]; [@b32-arh-34-1-106]; [@b69-arh-34-1-106]). Collectively, these studies indicate that the GABA neurotransmitter system is an important target of developmental ethanol exposure and that further investigation of the mechanisms of action of ethanol on this system is warranted.

Glutamate
=========

Glutamate is the main excitatory neurotransmitter in the mammalian brain and is locally synthesized from glucose. It binds to two classes of receptors: glutamate-gated ion channels and G protein--coupled receptors, which regulate a variety of intracellular signaling pathways via activation of G proteins (i.e., guanine nucleotide--binding proteins). There are three families of glutamate-gated ion channels, named for the compounds that were used to initially identify these channels: (1) the *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) receptor, (2) the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor, and (3) the kainate receptor (AMPA and kainate receptors are collectively known as non-NMDA receptors). There also are three families of G protein--coupled glutamate receptors, and these are denoted as group I, II, and III metabotropic glutamate receptors (mGluR I--III), based on their functional properties and effects on neuronal function.

Developmental Ethanol Exposure and the Glutamate Receptors
----------------------------------------------------------

### Short-Term Effects

A significant amount of research in recent years has focused on whether NMDA receptors in developing and mature neurons have the same sensitivity to ethanol. Interest in this issue was kindled, in part, by controversial findings that administration of NMDA receptor blockers during the third trimester--equivalent period triggers neuronal degeneration in many areas of the rat brain. As discussed above, drugs that potentiate GABA~A~ receptors and ethanol produced a similar effect ([@b33-arh-34-1-106]. For a detailed discussion of these findings, see [@b66-arh-34-1-106].) Given that numerous studies have shown that ethanol inhibits NMDA receptor function in mature neurons, it was hypothesized that ethanol acted, in part, by also inhibiting these receptors in immature neurons throughout the brain. Evidence supporting this hypothesis was found in a study with CA1 hippocampal neurons in slices from neonatal rats, where acute exposure to ethanol concentrations (0.18 to 0.36 g/dl) that are near those required to trigger neuronal degeneration (≥0.2 g/dl) inhibited NMDA receptor--mediated synaptic responses ([@b59-arh-34-1-106]). However, acute exposure to ethanol (0.32 g/dl) did not affect NMDA receptor--mediated currents in another neuronal population that was shown to be particularly sensitive to ethanol-induced cell death: neocortical layer II/III neurons from neonatal rats ([@b66-arh-34-1-106]).

[@b43-arh-34-1-106] also have reported finding no direct, acute inhibitory action of ethanol on NMDA receptors in another population of developing rat hippocampal neurons (CA3 pyramidal neurons). The study found that ethanol sensitivity in these receptors is gradually acquired after the third trimester--equivalent period has been completed. The researchers did report that ethanol directly inhibits AMPA receptors in these neurons during the third trimester--equivalent period and that this sensitivity gradually disappears as development progresses. NMDA and AMPA receptors have distinct subunit compositions during development and maturity, and this could explain the differences in ethanol sensitivity that were observed. In addition, this study found that ethanol can indirectly affect the function of both AMPA and NMDA receptors in developing neurons by decreasing glutamate release; this effect was detected during the third trimester--equivalent period and was mediated by inhibition of the N-type of Ca^2+^ channels that mediates glutamate release onto immature but not mature CA3 pyramidal neurons. Taken together, these findings suggest that if direct inhibition of NMDA receptors by ethanol damages developing neurons, this mechanism cannot be generalized to all brain regions.

An alternative possibility is that inhibition of NMDA receptors during ethanol exposure does not injure developing neurons but that damage actually occurs during ethanol withdrawal and that compensatory increases in NMDA receptor levels and/or function result in excessive ion flux through this channel, which is known to trigger neuronal toxicity. This model is supported by independent studies in which ethanol-induced long-lasting learning deficits were shown to be prevented by administration of NMDA receptor antagonists during withdrawal from exposure to high ethanol levels (see [table 1](#t1-arh-34-1-106){ref-type="table"}) in models of third trimester--equivalent, binge-like ethanol consumption ([@b41-arh-34-1-106]; [@b71-arh-34-1-106]).

As mentioned above with respect to GABA, synaptic potentiation mechanisms play a central role in synapse stabilization during the third trimester--equivalent period, and this also applies to glutamatergic synapses ([@b27-arh-34-1-106]). Researchers have hypothesized that ethanol could alter the maturation of glutamatergic circuits by interfering with synaptic potentiation mechanisms ([@b48-arh-34-1-106]). Initial studies ([@b42-arh-34-1-106]; [@b75-arh-34-1-106]) focused on the early portion of the third trimester--equivalent period found that acute exposure to ethanol caused long-lasting potentiation of AMPA receptor-mediated transmission in the CA1 hippocampal region of neonatal rats via the local production and/or release of a steroid-like molecule. However, this potentiating effect of ethanol was not observed under all conditions; acute ethanol exposure was subsequently found to inhibit CA1 AMPA receptor--mediated responses using a different experimental approach ([@b58-arh-34-1-106]). Moreover, this study also found that repeated in vivo ethanol exposure did not affect glutamatergic transmission in the CA1 region. Further research examined this issue during the late portion of the third trimester--equivalent period; acute exposure to high concentrations of ethanol (0.36 g/dl) impaired synaptic potentiation in the CA1 region, indicating that the mechanism of action of acute ethanol exposure involves, at least in part, inhibition of the function of both NMDA receptor-- and AMPA receptor--mediated synaptic responses ([@b59-arh-34-1-106]). Importantly, glutamatergic synaptic potentiation also was impaired in neonatal rats repeatedly exposed to high ethanol levels during the third trimester--equivalent period (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b60-arh-34-1-106]). Interestingly, in this in vivo study, neither AMPA nor NMDA receptor function was affected by repeated ethanol exposure, suggesting that acute and chronic ethanol exposure impair synaptic potentiation via different mechanisms. Collectively, these studies indicate that synaptic potentiation mechanisms in glutamatergic neuronal circuits are important targets of the short- and long-term actions of developmental ethanol exposure. Future studies should examine whether ethanol-induced impairments of these mechanisms alter maturation of hippocampal circuits and contribute to the long-lasting learning and memory deficits associated with FASD.

### Long-Term Effects

In comparison to the action of ethanol on glutamatergic receptor function during development, more studies have examined the long-lasting effects of ethanol on NMDA receptors because they are involved in cellular mechanisms that are thought to be important for learning and memory. NMDA receptor--dependent long-term potentiation of AMPA receptor--mediated synaptic responses may underlie these processes and has been shown to be impaired in FASD (reviewed in [@b11-arh-34-1-106]). The NMDA receptor typically is formed by two NR1 subunits and two NR2 subunits. A number of studies carried out between 1988 and 1999 (reviewed in [@b17-arh-34-1-106]) demonstrated that developmental ethanol exposure produces long-term changes in NMDA receptor levels in several brain regions. In the past decade, antibodies that selectively recognize specific NMDA receptor subunits have become widely available, and these have been used in several laboratories to further investigate the developmental effects of ethanol on NMDA receptor expression. These studies have yielded complex results that depend on the method of ethanol administration, dose of ethanol, brain region examined, experimental technique used to measure subunit levels, animal species, and animal age. Researchers have found increases, decreases, and no change in NMDA and/or AMPA receptor subunit levels (for examples see [@b19-arh-34-1-106]; [@b29-arh-34-1-106]; [@b53-arh-34-1-106]; [@b64-arh-34-1-106]). Long-lasting increases in NMDA receptor levels, coupled with elevated glucocorticoid and glutamate levels, could cause hippocampal damage, as suggested by a study with near-term fetal guinea pigs that were exposed throughout pregnancy to a high concentration of ethanol (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b35-arh-34-1-106]).

Long-lasting potentiation and other forms of synaptic plasticity (including long-term depression, the counterpart of long-lasting potentiation) can be impaired by certain patterns of developmental ethanol exposure, and this also could be a consequence of persistent alterations in NMDA receptor levels and/or function, including deficits in activation of NMDA receptor--dependent intracellular signaling pathways ([@b36-arh-34-1-106]; [@b45-arh-34-1-106]; [@b48-arh-34-1-106]; [@b63-arh-34-1-106]). For instance, NMDA receptor--dependent activation of extracellular receptor--activated kinase, a key enzyme that relays signals from the cell membrane to the nucleus during long-term synaptic potentiation, recently was shown to be impaired in adult mice exposed throughout pregnancy to relatively low levels of ethanol (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b65-arh-34-1-106]). The mechanisms responsible for these long-lasting effects of developmental ethanol exposure presently are unknown---including whether there is a connection between these and the developmental actions of ethanol on glutamatergic transmission---and none of these studies has conclusively linked these NMDA receptor alterations with behavioral deficits in animal models of FASD.

Long-lasting changes in AMPA receptor function also have been detected in a few recent studies. Increases in AMPA receptor function were detected in medial septum/diagonal band neurons from juvenile rats exposed to ethanol in a binge-like fashion during the third trimester--equivalent period (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b31-arh-34-1-106]). Decreases in frequency and amplitude of spontaneous AMPA receptor--mediated currents were found in CA1 hippocampal pyramidal neurons from 18- to 27-day-old rats exposed to ethanol in utero, and this effect was ameliorated by postnatal administration of an agent that stimulates AMPA receptor function (i.e., aniracetam) (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b80-arh-34-1-106], [@b81-arh-34-1-106]). Importantly, this aniracetam treatment regimen reversed learning and memory deficits that were present in untreated rats when they reached 40 days of age ([@b74-arh-34-1-106]). Clearly, further research efforts should focus on the role of AMPA receptors in the learning disabilities associated with FASD.

Metabotropic GluRs are powerful modulators of synaptic transmission in many brain regions, including the regulation of synaptic potentiation. Metabotropic GluRs have been implicated in learning and memory processes, as well as a human intellectual disabilities (Fragile X syndrome), where the absence of a protein encoded by the Fragile X mental retardation 1 (FMR1) gene causes dysregulation of mGluR-dependent signalling ([@b7-arh-34-1-106]). Metabotropic GluRs also are known to regulate proliferation, differentiation, and survival of neuronal progenitor cells ([@b15-arh-34-1-106]). Despite the importance of mGluRs for neuronal development, only a handful of studies have examined their role in FASD, and these have only focused on the long-term effects of ethanol. [@b61-arh-34-1-106] found a reduction in mGluR function in the hippocampus of adult offspring from rats exposed to ethanol during pregnancy (at a blood ethanol level of 0.08 g/dl). Similar findings were reported in another study with rats exposed to ethanol during gestational days 12 to 20 (blood ethanol levels not reported) ([@b55-arh-34-1-106]). In contrast, [@b76-arh-34-1-106] found that when rat dams were exposed to ethanol throughout gestation (maternal blood ethanol levels ∼0.1 g/dl) as well as during the lactation period (neonatal blood ethanol levels reported as very low), there was an increase in mGluR function in the hippocampus of juvenile offspring. More recently, [@b23-arh-34-1-106] showed that levels and function of a specific mGluR subunit (mGluR5) were decreased in part of the hippocampus (i.e., dentate gyrus) of adult offspring of rats gestationally exposed to ethanol (see [table 1](#t1-arh-34-1-106){ref-type="table"}). In another study, the long-term effects of ethanol were assessed in cultured cerebellar neurons obtained from embryonic day 20 rat fetuses. Exposure of these neurons to 0.15 g/dl of ethanol for 9 to 11 days decreased mGluR function; however, upon 1 day of withdrawal, these responses were enhanced ([@b54-arh-34-1-106]). These studies indicate that mGluRs are important targets of ethanol exposure during development and future research should investigate the role of these receptors in the behavioral abnormalities associated with FASD.

Serotonin
=========

This neurotransmitter, also known as 5-hydroxytryptamine (5-HT), is synthesized from tryptophan by the enzymes tryptophan hydroxylase and aromatic amino acid decarboxylase. It binds to two types of receptors: serotonin-gated ion channels (5-HT~3~ receptors) or G protein--coupled receptors (5-HT~1~, 5-HT~2~, and 5-HT~4--7~ receptors). The body of most serotonin neurons is located in a series of nuclei---known as the raphe nuclei---that are shaped like a seam and are located in the brain stem (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}). Some serotonergic projections from these nuclei descend to the spinal cord where they modulate pain transmission. Other projections ascend to brain regions such as the cortex, hippocampus, and hypothalamus (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}). In the mature brain, the serotonin neurotransmitter system is involved in the regulation of mood, attention, appetite, sleep, and other functions. Alterations in this neurotransmitter system have been linked to neuropsychiatric conditions, including depression. Serotonin is removed from synapses via reuptake mediated by transporters in the axon terminals, which are inhibited by antidepressant medications such as fluoxetine (Prozac^®^). Serotonin neurons are expressed early in development (embryonic day 12 in rodents), and serotonin released from these neurons has been shown to control progenitor cell proliferation, differentiation, migration, and synapse formation ([@b21-arh-34-1-106]). Therefore, the role of alterations in this transmitter system in FASD has been investigated in several laboratories, as these alterations could have a wide impact on neuronal circuit development across different brain regions.

Developmental Ethanol Exposure and Serotonin
--------------------------------------------

[@b25-arh-34-1-106] recently reviewed the effects of developmental ethanol exposure on the serotonergic neurotransmitter system, and the reader is referred to this article for more details. Briefly, studies have shown that developmental ethanol exposure, particularly when it involves exposure during the first and/or second trimester equivalents, decreases differentiation, migration, and axonal outgrowth of serotonin neurons. The mechanism underlying these effects may involve alterations in crosstalk between glial and neuronal cells. Serotonin neurons release serotonin onto glial cells, activating 5-HT~1A~ receptors expressed in these cells and inducing them to release neurotrophic factors (for instance, a protein known as S100P) that feed-back onto serotonin neurons to nurture them. Activators of 5-HT~1A~ receptors and some neuroprotective peptides have been shown to ameliorate the effects of ethanol on serotonin neuron development ([@b20-arh-34-1-106]; [@b84-arh-34-1-106]).

Several recent studies have investigated the impact of serotonin deficits induced by developmental ethanol exposure. [@b85-arh-34-1-106] found that decreased serotonin innervation correlated with reduced numbers of thalamocortical fibers, as well as decreased size of regions targeted by serotonin axons, including the hypothalamus, cerebral cortex, and hippocampus (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}). [@b38-arh-34-1-106] discovered a link among deficits in the brain stem serotonin system, prenatal ethanol exposure, prenatal nicotine exposure, and sudden infant death syndrome in autopsy cases from Native American Indians from the Northern Plains. Prenatal ethanol exposure is a major risk factor for sudden infant death syndrome, and this may be a consequence of ethanol--induced abnormalities in the maturation of serotonin neurons in the brain stem, where these neurons play an important role in the control of respiration, heart function, and blood pressure. In agreement with these human studies, developmental ethanol exposure in rats was shown to alter respiratory long-term facilitation, a serotonin-dependent protective mechanism that takes place in brain stem neurons in response to repeated events of low oxygenation ([@b37-arh-34-1-106]). In animals that are chronically exposed to ethanol, low oxygenation paradoxically induced long-term depression in these neurons in response to low oxygenation. Application of a 1-μM concentration of the serotonin analog, α-methyl-serotonin, induced respiratory long-term facilitation and depression in control and ethanol groups, respectively. These data are consistent with the model that prenatal ethanol exposure-induced alterations on serotonin modulation of brain stem neurons that control respiration could explain the high incidence of sudden infant death syndrome in FASD. [@b28-arh-34-1-106] observed complex gender-dependent effects on serotonergic modulation of the hypothalamic--pituitary--adrenal axis in adult rat offspring repeatedly exposed to ethanol during prenatal development. This axis is part of the neuroendocrine system and controls stress responses among other important physiological processes (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}). Moreover, [@b39-arh-34-1-106] reported evidence suggesting an interesting interaction between repeated prenatal ethanol exposures and a variation (DNA polymorphism) in the serotonin transporter gene. They found that prenatal ethanol exposed monkeys carrying this serotonin gene variation were more irritable as neonates and exhibited increased stress hormone levels. For more details on the role of serotonin and other neurotransmitters in alterations of stress responses by developmental ethanol exposure, which can be responsible for many of the alterations associated with FASD, including depression, anxiety, learning and memory deficits, and increased susceptibility to infections, see [@b40-arh-34-1-106] and [@b79-arh-34-1-106].

As mentioned above, alterations in the serotonin neurotransmitter system play a role in depression, and this mood disorder often is present in FASD patients ([@b56-arh-34-1-106]). Depressive-like behavior also has been detected in rodent models of FASD, and this could be a consequence of reductions in levels of BDNF (see GABA section above) ([@b13-arh-34-1-106]; [@b14-arh-34-1-106]). Antidepressant medications that act by inhibiting serotonin uptake have been shown to restore BDNF levels, suggesting that serotonin controls BDNF production by neurons ([@b46-arh-34-1-106]). It is therefore possible that deficits in serotonin transmission induced by developmental ethanol exposure result in long-lasting changes in BDNF levels and that this is, in part, responsible for the increased incidence of depression in FASD patients. Future studies should test this possibility.

Dopamine
========

This biogenic amine transmitter is synthesized from tyrosine by the enzymes tyrosine hydroxylase and [l]{.smallcaps}-aromatic amino acid decarboxylase. Dopamine binds to five types of G protein--coupled receptors that are grouped in two families: D~1~-like receptors (D~1~ and D~5~ receptors) and D~2~-like receptors (D~2~, D~3~, and D~4~ receptors). The action of dopamine is terminated by reuptake into axonal terminals via dopamine transporters. The cell bodies of dopaminergic neurons are located in the hypothalamus and in brain stem regions known as the substantia nigra pars compacta and the ventral tegmental area (see [figure 3](#f3-arh-34-1-106){ref-type="fig"}). Dopaminergic fibers project extensively throughout many brain regions, including the cortex, hippocampus, and striatum. In the mature brain, dopamine is involved in the regulation of movement, attention, motivation, and reward. Alterations in this neurotransmitter system have been linked to neurological disorders, such as Parkinson's disease (caused by degeneration of substantia nigra pars compacta dopaminergic neurons), as well as neuropsychiatric conditions such as schizophrenia, attention deficit disorder, and substance abuse. In the developing brain, dopamine regulates neuronal differentiation, migration (including that of GABAergic neurons), and axonal and/or dendritic growth ([@b21-arh-34-1-106]).

Developmental Ethanol Exposure and Dopamine
-------------------------------------------

Although it is well established that the dopaminergic system is an important target of the developmental actions of substances of abuse and environmental toxins ([@b21-arh-34-1-106]; [@b72-arh-34-1-106]), comparatively little is known about the actions of ethanol on this neurotransmitter system.

FASD is associated with attention deficits and increased susceptibility to substance abuse, and this could be the result of alterations in the dopaminergic neurotransmitter system. Studies carried out in the 1980s and 1990s demonstrated that repeated prenatal ethanol exposure decreases dopamine content and turnover, reduces D1 receptor levels, distorts the shape of dopaminergic neurons, and affects sensitivity of dopamine receptors to pharmacological agents (see [@b77-arh-34-1-106] and references therein). More recently, a positron emission tomography study detected complex alterations in the dopaminergic neurotransmitter system in young adult Rhesus monkeys that were exposed to low levels of ethanol during different phases of pregnancy (see [table 1](#t1-arh-34-1-106){ref-type="table"}) ([@b68-arh-34-1-106]). Other studies (see [@b77-arh-34-1-106] and references therein) have demonstrated that prenatal ethanol exposure persistently reduces the number of spontaneously active dopamine neurons in the ventral tegmental area and substantia nigra of developing and adult offspring (see [table 1](#t1-arh-34-1-106){ref-type="table"}). The mechanism by which ethanol produces this effect is unknown, but it appears to involve inactivation of a population of dopaminergic neurons in these regions. Importantly, methyphenidate (Ritalin^®^), a drug used to treat attention deficit disorders, restores normal dopaminergic neuronal activity for a prolonged period of time in rats exposed to ethanol prenatally ([@b70-arh-34-1-106]). The precise mechanism by which methylphenidate produces this effect is presently unknown.

In addition to mediating FASD-related attention deficits, alterations in the dopaminergic neurotransmitter system also could underlie the increased incidence of ethanol abuse and other substance abuse disorders that has been observed in individuals exposed to ethanol in utero as well as in animal models of FASD ([@b1-arh-34-1-106]; [@b2-arh-34-1-106]; [@b47-arh-34-1-106]; [@b82-arh-34-1-106]). [@b6-arh-34-1-106], [@b7-arh-34-1-106] found that exposure of rats to ethanol during pregnancy and lactation increased ethanol consumption and sensitivity to its anxiety-decreasing effects in adult offspring (see [table 1](#t1-arh-34-1-106){ref-type="table"}). These animals also exhibited increased sensitivity to the rewarding effects of cocaine and increased sensitization to cocaine and amphetamine (these drugs act in part by increasing levels of dopamine in the synapses). Decreases in D~1~ and/or dopamine transporter levels were detected in the striatum of these rats. [@b83-arh-34-1-106] recently reported that ethanol tasted and smelled better to the adolescent offspring of rats exposed to ethanol during pregnancy, resulting in increased ethanol intake. Although the mechanism of this effect is not fully understood, it may involve alterations in the levels of neurotransmitter genes in the olfactory bulb, including levels of the D~2~ receptor gene ([@b49-arh-34-1-106]). Future studies will be needed to determine if there is a link between these alterations in D~2~ receptor expression and changes in olfactory ethanol sensitivity.

Conclusion
==========

Research on the effects of developmental ethanol exposure on chemical neurotransmitter systems has significantly increased over the past decade. Studies have convincingly demonstrated that neurotransmission in the developing brain does not always respond to ethanol as in the adult brain and that components of developing neurotransmitter systems have unique properties that make them particularly sensitive to the adverse actions of ethanol, even at low levels of exposure. Ethanol-induced abnormalities in the formation and refinement of developing neuronal circuits are likely to be, in part, responsible for the persistent structural and functional brain deficits that characterize FASD. These deficits are ultimately responsible for the behavioral and cognitive alterations present in patients with this disorder and for their increased propensity to have comorbid neuropsychiatric diseases and some neurolgical disorders (see [figures 3](#f3-arh-34-1-106){ref-type="fig"} and [4](#f4-arh-34-1-106){ref-type="fig"}). Future studies should continue to investigate the mechanisms by which ethanol affects amino acid and biogenic amine neurotransmitter systems, and extend this work to other neurotransmitter systems, including peptide neurotransmitters. It is important to also continue to investigate the effects of developmental ethanol exposure on modulators of neurotransmission, as these may be key targets for the development of effective therapeutic interventions against FASD.
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![Potential sites of action of developmental ethanol exposure on neurotransmitter systems. **A)** Shown in the upper panel is a schematic representation of the components of a neuron, including the cell body and the ends of projections (axons and axon terminals) that release neurotransmitter onto branch-like projections (dendrites) in adjacent neurons. Note that the axons make synaptic connections with dendrites from three adjacent neurons. Shown in the lower panel is a synapse in more detail. In axonal terminals, neurotransmitters are synthesized and packaged into synaptic vesicles. Release of the neurotransmitter is triggered by influx of Ca^2+^ via voltage-gated Ca^2+^ channels. Neurotransmitter release can be modulated by neurotransmitter-gated ion channels and G protein--coupled receptors expressed in axonal terminals. Neurotransmitters act by activating neurotransmitter-gated ion channels and G protein--coupled receptors expressed in target neurons (either at postsynaptic or extrasynaptic locations). One mechanism by which the action of the neurotransmitter can be terminated is by reuptake into the axonal terminal or neighboring glial cells via neurotransmitter transporters. **B)** Upper panel: developmental ethanol exposure could affect a given neurotransmitter system by decreasing the number of neurons, dendrite and axonal length and/or number, and/or modifying the number and/or efficacy of synapses. Lower panel: developmental ethanol exposure can affect any of the components involved in neurotransmission. In this hypothetical example, ethanol exposure decreased neurotransmitter release, and this led to a compensatory increased in the levels of postsynaptic and extrasynaptic neurotransmitter receptors in the target neuron.](arh-34-1-106f1){#f1-arh-34-1-106}

![γ-Aminobutyric acid (GABA)~A~ receptors stimulate immature neurons and inhibit mature neurons. **A)** In immature neurons, intracellular Cl^−^ concentrations are higher than in mature neurons. This is a consequence of low expression of a Cl^−^ exporter (potassium/chloride cotransporter type 2; KCC2) and high expression of a Cl^−^ importer (sodium/potassium/chloride cotransporter type 1; NKCC1). Activation of GABA~A~ receptors causes Cl^−^ flux out of the cell, which makes the membrane potential more positive, leading to activation of Ca^2+^ channels. **B)** In mature neurons, intracellular Cl^−^ concentrations are low. This is a consequence of high expression of a Cl^−^ exporter and low expression of a Cl^−^ importer. Activation of GABA~A~ receptors causes Cl^−^ flux into the cell, which makes the membrane potential more negative. Ca^2+^ channels are not activated under these conditions. The unique properties of GABA~A~ receptors during development make them especially vulnerable to ethanol (see text).](arh-34-1-106f2){#f2-arh-34-1-106}

![Examples of brain regions where chemical neurotransmitter system alterations have been demonstrated in models of fetal alcohol spectrum disorders (FASD). Shown is a schematic representation of the mature human brain. The potential FASD-linked conditions that could be explained by neurotransmitter system alterations are given under the label for each region. Anxiety and abnormal stress responses (serotonin) apply both to hypothalamus and pituitary. Examples of neurotransmitters that could potentially be involved in these deficits are given in parenthesis.](arh-34-1-106f3){#f3-arh-34-1-106}

![Diagram illustrating the potential role of neurotransmitter system alterations in fetal alcohol spectrum disorders (FASD). Ethanol exposure during development, acting in conjunction with genetic susceptibility factors (for instance, variations in the serotonin transporter gene) and environmental factors (for example, coexposure to nicotine), disrupts the actions of neurotransmitter systems (i.e., biogenic amines, etc) that normally interact in a complex manner to regulate the key processes involved in brain development (i.e. proliferation, etc). Disruption of these processes results in persistent alterations in synaptic transmission/plasticity and neuronal network function. These alterations likely underlie the deficits associated with FASD (i.e., learning and memory deficits). The precise chain of events leading from developmental ethanol exposure to these deficits remains to be determined.](arh-34-1-106f4){#f4-arh-34-1-106}

###### 

Examples of Recent Studies on the Effects of Developmental Ethanol Exposure on Neurotransmitter Systems[\*](#tfn2-arh-34-1-106){ref-type="table-fn"}

  **Neurotransmitter System**                                                                                                                                                                                         **Effect of Developmental Exposure**                                                                                                                               **Exposure Period[†](#tfn3-arh-34-1-106){ref-type="table-fn"}**   **Mode of Ethanol Administration**                            **Blood Ethanol Levels (g/dl)[‡](#tfn4-arh-34-1-106){ref-type="table-fn"}**   **Species**                                  **Reference**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------- -----------------------
  γ--Aminobutyric acid (GABA)                                                                                                                                                                                         Premature migration of cortical GABAergic interneurons at E14.5                                                                                                    E0.5--E14.5                                                       Liquid diet                                                   0.025 (maternal)                                                              Mice                                         ([@b18-arh-34-1-106])
  Altered plasticity and firing of cerebellar GABAergic neurons (Purkinje) at P15--P20                                                                                                                                E0--E21                                                                                                                                                            Drinking water                                                    0.08 (maternal)                                               Mice                                                                          ([@b69-arh-34-1-106])                        
  Decrease in levels of GABA~A~ receptor α5 subunit at E18 and increased expression in adults                                                                                                                         E8                                                                                                                                                                 Intraperitoneal injection                                         Not determined                                                Mice                                                                          ([@b73-arh-34-1-106])                        
  Increase in levels of GABA~A~ receptor α~1~ and β~2/3~ subunit in adults                                                                                                                                            E2--E67                                                                                                                                                            Oral intubation                                                   0.32 (maternal)                                               Guinea Pigs                                                                   ([@b3-arh-34-1-106])                         
  Decrease in cortical GABAergic (and glutamatergic) neuronal numbers during adolescence                                                                                                                              E3--E42/168                                                                                                                                                        Intragastric intubation                                           0.23 (maternal)                                               Monkeys                                                                       ([@b50-arh-34-1-106])                        
  Impaired brain-derived neurotrophic factor (BDNF)-dependent plasticity of hippocampal GABAergic transmission at P4--P6                                                                                              P2--P6                                                                                                                                                             Vapor chambers                                                    0.025--0.18 (neonate)                                         Rats                                                                          ([@b86-arh-34-1-106])                        
  Delayed GABAergic current maturation in medial septum/diagonal band neurons at P12--P15                                                                                                                             P4--P6                                                                                                                                                             Oral intubation                                                   0.28 (neonate)                                                Rats                                                                          ([@b30-arh-34-1-106])                        
  Widespread neuronal death at P8 potentially caused by ethanol-induced enhancement of GABA~A~ receptors (and inhibition of *N*-methyl-[d]{.smallcaps}-aspartic acid \[NMDA\] receptors)                              P7                                                                                                                                                                 Subcutaneous injection                                            ≥0.2 (neonate)                                                Rats                                                                          ([@b33-arh-34-1-106])                        
  Glutamate                                                                                                                                                                                                           Increase in hippocampal glutamate and NMDA receptor levels at E63                                                                                                  E2--E63                                                           Oral intubation                                               0.28 (maternal)                                                               Guinea Pigs                                  ([@b35-arh-34-1-106])
  Impaired glutamatergic transmission and plasticity in the hippocampus                                                                                                                                               E2--E67                                                                                                                                                            Oral intubation                                                   0.28 (maternal)                                               Guinea Pigs                                                                   ([@b63-arh-34-1-106])                        
  Impaired NMDA receptor--dependent activation of extracellular receptor--activated kinase                                                                                                                            E0--E21                                                                                                                                                            Voluntary drinking using two bottle choice paradigm               g 0.08 (maternal)                                             Mice                                                                          ([@b65-arh-34-1-106])                        
  Decrease in NR2A and NR2B NMDA subunit mRNA in the hippocampus. Increase in NR2A mRNA in the cortex and NR2B in cortex and cerebellum.                                                                              E8                                                                                                                                                                 Intraperitoneal injection                                         Not determined                                                Mice                                                                          ([@b34-arh-34-1-106])                        
  Learning or motor deficits in adult animals that could be prevented by NMDA receptor antagonism during withdrawal                                                                                                   P6 (learning) P1--P8 (motor                                                                                                                                        ) Gastric intubation                                              0.3--0.4 (learning) 0.22 (motor) (neonate)                    Rats                                                                          ([@b41-arh-34-1-106]; [@b71-arh-34-1-106])   
  Impaired hippocampal glutamatergic plasticity at P7--P9                                                                                                                                                             P2--P9                                                                                                                                                             Vapor chambers                                                    0.3--0.4 (neonate)                                            Rats                                                                          (Valenzuela 2010*b*)                         
  Impaired hippocampal plasticity at P30                                                                                                                                                                              P9                                                                                                                                                                 Subcutaneous injection                                            0.2--0.5 (neonate)                                            Rats                                                                          ([@b36-arh-34-1-106])                        
  Decrease in AMP-activated protein kinase (AMPA) receptor currents in the hippocampus at P18--P27                                                                                                                    E3--E20                                                                                                                                                            Intragastric intubation                                           0.18 (maternal)                                               Rats                                                                          ([@b80-arh-34-1-106])                        
  Increase in AMPA receptor function in medial septum/diagonal band neurons at P32--P35                                                                                                                               P4--P9                                                                                                                                                             Oral intubation                                                   0.35 (neonate)                                                Rats                                                                          ([@b31-arh-34-1-106])                        
  Decrease in levels and function of mGluR5 in the dentate gyrus of adult animals                                                                                                                                     E3--E21                                                                                                                                                            Liquid diet                                                       0.07--0.14 (maternal)                                         Rats                                                                          ([@b23-arh-34-1-106])                        
  Serotonin                                                                                                                                                                                                           Decreased serotonin innervation correlated with decreased size in regions targeted by this transmitter at E15--E18                                                 E7--E15/18                                                        Liquid diet                                                   0.07--0.14 (maternal)                                                         Rats                                         ([@b85-arh-34-1-106])
  Increased incidence in sudden infant death syndrome that correlated with serotonergic abnormalities in the brain stem at 40--90 postconceptional weeks                                                              Unknown                                                                                                                                                            Oral ingestion                                                    Unknown                                                                                                                                     ([@b38-arh-34-1-106])                        
  Impaired serotonin-dependent respiratory long-term facilitation of brain stem neurons at P5--P7                                                                                                                     E0--E21                                                                                                                                                            Drinking water                                                    0.08 (maternal)                                               Rats                                                                          ([@b37-arh-34-1-106])                        
  Alterations in serotonergic modulation of hypothalamic--pituitary--adrenal axis                                                                                                                                     E1--E21                                                                                                                                                            Liquid diet                                                       Not determined                                                Rats                                                                          ([@b28-arh-34-1-106])                        
  Presence of a serotonin transporter DNA sequence variation (polymorphism) was associated with increased irritability and stress hormone levels during the neonatal period in animals exposed to ethanol in utero.   E0--E164                                                                                                                                                           Oral ingestion                                                    0.02--0.05 (maternal)                                         Monkeys                                                                       ([@b39-arh-34-1-106])                        
  Dopamine                                                                                                                                                                                                            Persistent reduction in number of spontaneously active dopaminergic neurons in the ventral tegmental area and substantia nigra of developing and adult offspring   E8--E20                                                           Gastric intubation                                            0.3 (maternal)                                                                Rats                                         ([@b77-arh-34-1-106])
  Decrease in D1 receptor and dopamine transporter levels                                                                                                                                                             E0--E21 plus lactation                                                                                                                                             Drinking water and mother's milk                                  0.08 (maternal)[§](#tfn5-arh-34-1-106){ref-type="table-fn"}   Rats                                                                          ([@b6-arh-34-1-106])                         
  Early-gestation ethanol exposure reduced dopaminergic function in adulthood. Middle- to late-gestation exposure heightened dopaminergic function                                                                    E0--E50, E50--E135, or E0--E135                                                                                                                                    Oral ingestion                                                    0.02--0.05 (maternal)                                         Monkeys                                                                       ([@b68-arh-34-1-106])                        

NOTE:

Only recent studies that used in vivo ethanol exposure paradigms were included. See text for discussion of in vitro studies on the acute effects of ethanol.

Duration of pregnancy is approximately 21 days in rats and mice, 68 days in guinea pigs, 160--180 days in monkeys, and 280 days in humans. E, embryonic; P, postnatal

Legal intoxication limit in the U.S. = 0.08 g/dl.

Levels in nursing pups were not measured but are expected to be significantly lower than maternal levels.
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